The proposed amendments to the Regulation on the Permission, Notification, Review, Etc. of In Vitro Diagnostic Medical Devices are as follows: A. Exemption from raw material declaration requirements in manufacturing (import) notifications for in vitro diagnostic equipment B. Relaxation of requirements for clinical performance study data for IVD approval C. Elimination of notarization requirements for translations of documents in foreign languages other than English D. Expansion of the scope of exemption from sales business notification for in vitro diagnostic medical devices in response to public health crisis E. Expedited review for re-applications of IVD approval